The correlation between nucleolin and biological behavior of tumor

Abstract

WANG Xiao, GAO Yong, LI Yan-Dong. The correlation between nucleolin and biological behavior of tumor[J]. Journal of International Oncology, 2016, 43(2): 119-.

［1］ Durut N, SáezVásquez J. Nucleolin: dual roles in rDNA chromatin transcription［J］. Gene, 2015, 556(1): 712. DOI:10.1016/j.gene.2014.09.023. ［2］ Abdelmohsen K, Gorospe M. RNAbinding protein nucleolin in disease［J］. RNA Biol, 2012, 9(6): 799808. DOI:10.4161/rna.19718. ［3］ Berger CM, Gaume X, Bouvet P. The roles of nucleolin subcellular localization in cancer［J］. Biochimie, 2015, 113: 7885. DOI:10.1016/j.biochi.2015.03.023. ［4］ Guo X, Xiong L, Yu L, et al. Increased level of nucleolin confers to aggressive tumor progression and poor prognosis in patients with hepatocellular carcinoma after hepatectomy［J］. Diagn Pathol, 2014, 9: 175. DOI:10.1186/s130000140175y. ［5］ Qiu W, Zhou F, Zhang Q, et al. Overexpression of nucleolin and different expression sites both related to the prognosis of gastric cancer［J］. APMIS, 2013, 121(10): 919925. DOI:10.1111/apm.12131. ［6］ Koutsioumpa M, Polytarchou C, Courty J, et al. Interplay between αvβ3 integrin and nucleolin regulates human endothelial and glioma cell migration［J］. J Biol Chem, 2013, 288(1): 343354. DOI:10.1074/jbc.M112.387076. ［7］ Fujiki H, Watanabe T, Suganuma M. Cellsurface nucleolin acts as a central mediator for carcinogenic, anticarcinogenic, and diseaserelated ligands［J］. J Cancer Res Clin Oncol, 2014, 140(5): 689699. DOI:10.1007/s0043201415875. ［8］ Qi J, Li H, Liu N, et al. The implications and mechanisms of the extranuclear nucleolin in the esophageal squamous cell carcinomas［J］. Med Oncol, 2015, 32(3): 45. DOI:10.1007/s1203201504843. ［9］ Xiao S, Caglar E, Maldonado P, et al. Induced expression of nucleolin phosphorylationdeficient mutant confers dominantnegative effect on cell proliferation［J］. PLoS One, 2014, 9(10): e109858. DOI:10.1371/journal.pone.0109858. ［10］ Wu DM, Zhang P, Liu RY, et al. Phosphorylation and changes in the distribution of nucleolin promote tumor metastasis via the PI3K/Akt pathway in colorectal carcinoma［J］. FEBS Lett, 2014, 588(10): 19211929. DOI:10.1016/j.febslet.2014.03.047. ［11］ Wang W, Luo J, Xiang F, et al. Nucleolin downregulation is involved in ADPinduced cell cycle arrest in S phase and cell apoptosis in vascular endothelial cells［J］. PLoS One, 2014, 9(10): e110101. DOI:10.1371/journal.pone.0110101. ［12］ Srivastava A, Srivastava S, Bansal C, et al. Diagnostic importance of AgNOR pleomorphism in cervical carcinogenesis［J］. Ecancermedicalscience, 2013, 7: 287. DOI:10.3332/ecancer.2013.287. ［13］ Malik MT, O′toole MG, Casson LK, et al. AS1411conjugated Gold nanospheres and their potential for breast cancer therapy［J］. Oncotarget, 2015, 6(26): 2227022281. ［14］ Liao ZX, Chuang EY, Lin CC, et al. An AS1411 aptamerconjugated liposomal system containing a bubblegenerating agent for tumorspecific chemotherapy that overcomes multidrug resistance［J］. J Control Release, 2015, 208: 4251. DOI:10.1016/j.jconrel.2015.01.032. ［15］ Wang WH, Childress MO, Geahlen RL. Syk interacts with and phosphorylates nucleolin to stabilize Bclx(L) mRNA and promote cell survival［J］. Mol Cell Biol, 2014, 34(20): 37883799. DOI:10.1128/MCB.0093714. ［16］ Wise JF, Berkova Z, Mathur R, et al. Nucleolin inhibits Fas ligand binding and suppresses Fasmediated apoptosis in vivo via a surface nucleolinFas complex［J］. Blood, 2013, 121(23): 47294739. DOI:10.1182/blood201212471094. ［17］ Cheng DD, Zhao HG, Yang YS, et al. GSK3β negatively regulates HIF1α mRNA stability via nucleolin in the MG63 osteosarcoma cell line［J］. Biochem Biophys Res Commun, 2014, 443(2): 598603. DOI:10.1016/j.bbrc.2013.12.020. ［18］ Sletten T, Kostas M, Bober J, et al. Nucleolin regulates phosphorylation and nuclear export of fibroblast growth factor 1 (FGF1)［J］. PLoS One, 2014, 9(3): e90687. DOI:10.1371/journal.pone.0090687. ［19］ Hsu TI, Lin SC, Lu PS, et al. MMP7mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy［J］. Oncogene, 2015, 34(7): 826837. DOI:10.1038/onc.2014.22. ［20］ Subramanian N, Kanwar JR, Akilandeswari B, et al. Chimeric nucleolin aptamer with survivin DNAzyme for cancer cell targeted delivery［J］. Chem Commun (Camb), 2015, 51(32): 69406943. DOI:10.1039/c5cc00939a. ［21］ Lee JW, Kim HJ, Heo K. Therapeutic aptamers: developmental potential as anticancer drugs［J］. BMB Rep, 2015, 48(4): 234237. ［22］ Qiu W, Wang G, Sun X, et al. The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinoma［J］. Med Oncol, 2015, 32(3): 75. DOI:10.1007/s1203201505301. ［23］ Goldstein M, Derheimer FA, TaitMulder J, et al. Nucleolin mediates nucleosome disruption critical for DNA doublestrand break repair［J］. Proc Natl Acad Sci USA, 2013, 110(42): 1687416879. DOI:10.1073/pnas.1306160110. ［24］ Koutsioumpa M, Papadimitriou E. Cell surface nucleolin as a target for anticancer therapies［J］. Recent Pat Anticancer Drug Discov, 2014, 9(2): 137152.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang. Role of PFDN and its subunits in tumorigenesis and tumor development [J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun. Advances in anti-tumor drugs with new mechanisms of action [J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang. Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma [J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin. Study on the clinical relationship between inflammatory burden index and gastric cancer [J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying. Research progress of habitat analysis in radiomics of malignant tumors [J]. Journal of International Oncology, 2024, 51(5): 292-297.

The correlation between nucleolin and biological behavior of tumor

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments